Ledger. Australian venture funding, tracked

Company

Sadleir Laboratories

IRIS, a precision drug-mixing syringe for delivering IV antibiotics to surgical patients with an antibiotic allergy label

What Sadleir Laboratories bought

Companies Sadleir Laboratories acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.

Company KindAnnounced Price Sources
Sadleir Laboratories is not recorded as having acquired anything.

Something wrong? Tell us